Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amniotic Fluid Biomarker Research for Prediction of Postnatal Renal Function in Fetus With a Bilateral Abnormal Renal Development: National, Multicenter, Prospective and Non-interventional Study.

NCT02675686 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT02675686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02675686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amniotic Fluid Biomarker Research for Prediction of Postnatal Renal Function in Fetus With a Bilateral Abnormal Renal Development: National, Multicenter, Prospective and Non-interventional Study.
Lead sponsor
University Hospital, Toulouse
Phase
Observational
Overall status
Completed
Start date
December 31, 2010
Completion date
December 31, 2016
Enrollment
358 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

nephropathy